Keyword Connections

myeloproliferative neoplasms

Journals

11

1 the journal of knee surgery

2 hematological oncology

3 European journal of neurology

4 British journal of haematology

5 journal of the national comprehensive cancer network : jnccn

6 seminars in respiratory and critical care medicine

7 zeitschrift fur gastroenterologie

8 cancer treatment and research

9 advances in biological regulation

10 hematology american society of hematology education program

11 seminars in hematology

Research Groups

0

No Research Group Connected

Bibliographies

21

1 Low-dose methotrexate: potential clinical impact on haematological and constitutional symptoms in myeloproliferative neoplasms.

2 [Survey: Why did you become a gastroenterologist?]

3 Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.

4 Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors.

5 Recurrent ischaemic cerebrovascular events as presenting manifestations of myeloproliferative neoplasms.

6 Do All Patients With Polycythemia Vera or Essential Thrombocythemia Need Cytoreduction?

7 Heterogeneity in myeloproliferative neoplasms: Causes and consequences.

8 Managing myelofibrosis (MF) that "blasts" through: advancements in the treatment of relapsed/refractory and blast-phase MF.

9 Somatic Mutations in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.

10 Management of advanced phase myeloproliferative neoplasms.

11 Pathogenesis and Management of Thrombotic Disease in Myeloproliferative Neoplasms.

12 Revised myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia

13 Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia

14 Comparative study of different methodologies to detect the JAK2 V617F mutation in chronic BCR-ABL1 negative myeloproliferative neoplasms

15 Clinical Features of 294 Turkish Patients with Chronic Myeloproliferative Neoplasms

16 Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms

17 Analysis of saliva samples and cluster of differentiation 3 (CD3)+ lymphocytes as a source of germline DNA in myeloproliferative neoplasms.

18 a paraneoplastic syndrome characterized by extremity swelling with associated inflammatory infiltrate heralds aggressive transformation of myelodysplastic syndromes/myeloproliferative neoplasms to acute myeloid leukemia: a case series

19 a multiplex snapback primer system for the enrichment and detection of jak2 v617f and mpl w515l/k mutations in philadelphia-negative myeloproliferative neoplasms

20 chronic myeloproliferative neoplasms: a collaborative approach

21 the european clinical, molecular, and pathological (ecmp) criteria and the 2007/2008 revisions of the world health organization for the diagnosis, classification, and staging of prefibrotic myeloproliferative neoplasms carrying the jak2v617f mutation